{"DataElement":{"publicId":"2182785","version":"1","preferredName":"First Dose Date","preferredDefinition":"The date the participant started taking the agent for the specified visit period.","longName":"FIRST_DOSE_DT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2189798","version":"1","preferredName":"Treatment First Quantity","preferredDefinition":"information related to the first treatment quantity or dose.","longName":"TX_FIRST_QTY","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2176930","version":"1","preferredName":"Treatment","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"Treatment","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7B00-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207361","version":"1","preferredName":"First Quantity","preferredDefinition":"Preceding all others in time or space or degree.:Quantity; how much there is of something that you can measure.","longName":"C25509:C25256","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Quantity","conceptCode":"C25256","definition":"How much there is of something that you can measure; the total amount or number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2155-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E632069E-09FF-3693-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018550","version":"1","preferredName":"Date","preferredDefinition":"The date on which an observation was made or an event occurred.","longName":"DT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"format":"MM/DD/YYYY","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233081","version":"1","preferredName":"Date","preferredDefinition":"a particular day specified as the time something has, or will, happen.","longName":"C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F90B5E56-BB15-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B54EF112-5457-674A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-28","modifiedBy":"ZHWENDY","dateModified":"2023-12-12","changeDescription":"8/3/17 tt added Diagnosis CSI. 6/20/17 jk transferred to NCI Standards per confirmation by Brian Campbell as part of Round 5 finalization task, added reg status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2179692","version":"1","longName":"TYPE OF CATEGORY","context":"DCP","ClassificationSchemeItems":[{"publicId":"2811734","version":"1","longName":"Case Report Forms","context":"DCP"},{"publicId":"2957372","version":"1","longName":"Case Report Forms Version 3","context":"DCP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812399","version":"1","longName":"Polyphenon E for Cervical Ca","context":"DCP"},{"publicId":"2812388","version":"1","longName":"Oral Leukoplakia","context":"DCP"},{"publicId":"2812377","version":"1","longName":"Bladder Cancer","context":"DCP"},{"publicId":"2812415","version":"1","longName":"Sulindac for Breast Cancer","context":"DCP"},{"publicId":"2812364","version":"1","longName":"Barretts Esophagus","context":"DCP"},{"publicId":"2812516","version":"1","longName":"Subclinical Neoplastic Lesions","context":"DCP"},{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812155","version":"1","longName":"Sporadic Colorectal Neoplasia - Atrovastatin","context":"DCP"},{"publicId":"2812202","version":"1","longName":"DIM - Prostate Cancer","context":"DCP"},{"publicId":"2812183","version":"1","longName":"Atrovastatin in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812182","version":"1","longName":"Tissue Effect of Finasteride - Prostate Cancer","context":"DCP"},{"publicId":"2812174","version":"1","longName":"Polyphenon E - Hormone Receptor-Negative Breast Cancer","context":"DCP"},{"publicId":"2812157","version":"1","longName":"Melanoma Pathobiology - Lovastatin","context":"DCP"},{"publicId":"2812152","version":"1","longName":"Barretts Esophagus - ASA-Esomeprazole","context":"DCP"},{"publicId":"2812102","version":"1","longName":"Budesonide Lung Nodules","context":"DCP"},{"publicId":"2812148","version":"1","longName":"SAMe - Hepatitis C cirrhosis","context":"DCP"},{"publicId":"2812154","version":"1","longName":"Bronchial Dysplasia - Sulindac","context":"DCP"},{"publicId":"2812149","version":"1","longName":"Pancreatic Mucinous Neoplasms","context":"DCP"},{"publicId":"2812151","version":"1","longName":"Prostate - Lycopene","context":"DCP"},{"publicId":"2812184","version":"1","longName":"Spectral Markers in ASA","context":"DCP"},{"publicId":"2812768","version":"1","longName":"PK and Safety - Novel Retinoid (9cUAB30)","context":"DCP"},{"publicId":"2812539","version":"1","longName":"Polyphenon E - Bladder Cancer","context":"DCP"},{"publicId":"2812876","version":"1","longName":"Bronchial Dysplasia - Myo-Inositol","context":"DCP"},{"publicId":"2812551","version":"1","longName":"9cUAB30","context":"DCP"},{"publicId":"2812194","version":"1","longName":"ALA PDT - Oral Leukoplakia","context":"DCP"},{"publicId":"2812553","version":"1","longName":"EGF Receptor Signaling in ACF","context":"DCP"},{"publicId":"2812843","version":"1","longName":"Polyethylene Glycol - Colon Carcinogenesis","context":"DCP"},{"publicId":"2842768","version":"1","longName":"Letrozole - Breast Cancer","context":"DCP"},{"publicId":"2812735","version":"1","longName":"3, 3-Diindolylmethane Cervical Intraepithelial","context":"DCP"},{"publicId":"2813002","version":"1","longName":"Sulindac - Increased Risk of Melanoma","context":"DCP"},{"publicId":"2812998","version":"1","longName":"Pioglitazone - Oral Leukoplakia","context":"DCP"},{"publicId":"2812736","version":"1","longName":"Transdermal 4-OHT vs oral TAM DCIS of the Breast","context":"DCP"},{"publicId":"2813064","version":"1","longName":"Erlotinib - Lesions of Lung","context":"DCP"},{"publicId":"2859628","version":"1","longName":"Breast Sulindac DFMO","context":"DCP"},{"publicId":"2813043","version":"1","longName":"Ursodeoxycholic Acid - Barrett's Patients","context":"DCP"},{"publicId":"3303133","version":"1","longName":"Pomegranate - Prostate Cancer","context":"DCP"},{"publicId":"2979172","version":"1","longName":"MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia","context":"DCP"},{"publicId":"2936518","version":"1","longName":"Polyphenon E in Women w/ Modulation of Arachidonic Acid","context":"DCP"},{"publicId":"3018781","version":"1","longName":"Metformin Colorectal Cancer","context":"DCP"},{"publicId":"3018782","version":"1","longName":"Resveratrol in Postmenopausal Women","context":"DCP"},{"publicId":"3114163","version":"1","longName":"Cholecalciferol and Genistein","context":"DCP"},{"publicId":"3110219","version":"1","longName":"MSC and L SeMet in Adult Men","context":"DCP"},{"publicId":"3152820","version":"1","longName":"Pioglitazone - Lung Pre-Surgical NSCLC","context":"DCP"},{"publicId":"3182879","version":"1","longName":"Metformin - Pre-Prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"3211792","version":"1","longName":"Barrett's Esophagus Chemoprevention Metformin","context":"DCP"},{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"},{"publicId":"3182878","version":"1","longName":"Vitamin D - Bioactivity in the Skin","context":"DCP"},{"publicId":"3293737","version":"1","longName":"UAB30 in NMSC","context":"DCP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5889177","version":"1","longName":"MDA2016-08-02","context":"DCP"},{"publicId":"3896537","version":"1","longName":"UWI2013-01-02","context":"DCP"},{"publicId":"3896538","version":"1","longName":"UAZ2013-01-01","context":"DCP"},{"publicId":"4111771","version":"1","longName":"UWI2013-00-01","context":"DCP"},{"publicId":"4261112","version":"1","longName":"UAZ2013-02-01","context":"DCP"},{"publicId":"4261412","version":"1","longName":"MDA2013-01-01","context":"DCP"},{"publicId":"4188651","version":"1","longName":"MDA2013-01-02","context":"DCP"},{"publicId":"4528055","version":"1","longName":"UAZ2014-03-01","context":"DCP"},{"publicId":"4528053","version":"1","longName":"NWU2014-03-01","context":"DCP"},{"publicId":"4915511","version":"1","longName":"UAZ2015-05-01","context":"DCP"},{"publicId":"4915512","version":"1","longName":"UAZ2015-05-02","context":"DCP"},{"publicId":"5416571","version":"1","longName":"MDA2013-02-02","context":"DCP"},{"publicId":"5598962","version":"1","longName":"MDA2014-04-01","context":"DCP"},{"publicId":"5981652","version":"1","longName":"UAZ2017-09-02","context":"DCP"},{"publicId":"5889185","version":"1","longName":"UWI2016-08-01","context":"DCP"},{"publicId":"6025104","version":"1","longName":"MAY2016-08-01","context":"DCP"},{"publicId":"6046252","version":"1","longName":"UAZ2016-08-02","context":"DCP"},{"publicId":"5889176","version":"1","longName":"MDA2016-07-02","context":"DCP"},{"publicId":"5889178","version":"1","longName":"MDA2017-09-03","context":"DCP"},{"publicId":"5280817","version":"1","longName":"UWI2016-07-01","context":"DCP"},{"publicId":"5889187","version":"1","longName":"UWI2017-09-01","context":"DCP"},{"publicId":"5280816","version":"1","longName":"UWI2015-05-01","context":"DCP"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"DCP"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"First Dose taken this period","type":"Preferred Question Text","description":"First Dose taken this period date","url":null,"context":"DCP"},{"name":"DCP Question Text 2","type":"Alternate Question Text","description":"Dose taken","url":null,"context":"DCP"},{"name":"Date Agent Started","type":"Alternate Question Text","description":"Date Agent Started","url":null,"context":"DCP"},{"name":"Second Dose Taken","type":"Alternate Question Text","description":"Second Dose Taken","url":null,"context":"DCP"},{"name":"Third Dose Taken","type":"Alternate Question Text","description":"Third Dose Taken","url":null,"context":"DCP"},{"name":"Fourth Dose Taken","type":"Alternate Question Text","description":"Fourth Dose Taken","url":null,"context":"DCP"},{"name":"DCP Text 1","type":"Alternate Question Text","description":"First Dose received by subject:","url":null,"context":"DCP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Date of first dose during this reporting period:","url":null,"context":"COG"},{"name":"CRF Text1","type":"Alternate Question Text","description":"what date did you first use this:","url":null,"context":"Alliance"},{"name":"CRF Text2","type":"Alternate Question Text","description":"What date did you take your first dose?","url":null,"context":"Alliance"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Start date of 1st treatment of IVIG:","url":null,"context":"COG"},{"name":"DCP-Text-3","type":"Alternate Question Text","description":"First Dose taken this period","url":null,"context":"DCP"},{"name":"DCP-Text-4","type":"Alternate Question Text","description":"Date first dose administered/taken this period","url":null,"context":"DCP"},{"name":"DCP Text 5","type":"Alternate Question Text","description":"Date first dose taken by subject","url":null,"context":"DCP"},{"name":"DCP-Text-6","type":"Alternate Question Text","description":"First Dose applied this period date","url":null,"context":"DCP"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Date of patient's first Vincristine dose:","url":null,"context":"COG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"First date of Levocarnitine administration:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D751C8E1-83EB-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-04-08","modifiedBy":"KUMMEROA","dateModified":"2022-11-04","changeDescription":null,"administrativeNotes":"2022.10.20 AQT added for ticket request CADSR0001614. ak 2022.11.4 AQT added for ticket request CADSR0001656. ak","unresolvedIssues":null,"deletedIndicator":"No"}}